The company said it will submit data about its booster dose to the US FDA and apply for emergency use authorisation. It is also planning a new trial to test an updated version of its two-dose vaccine that targets the Delta variant. Pfizer and BioNTech plan to file for US emergency use authorisation for a booster dose of their Covid-19 vaccine, the company announced on Thursday. As of 8 July, 378 403 people have been fully vaccinated with the Pfizer vaccine, while 875 575 people have received the single-dose Johnson & Johnson vaccine, News24 reported. READ | Covid-19 vaccine safety: We speak to Pfizer's medical director in SA – Part 1READ | Covid-19 vaccine safety: We speak to Pfizer's medical director in SA – Part 2READ | Covid-19 vaccine myths debunked: Get the facts here

Source: News 24 July 12, 2021 03:00 UTC